Palantir (PLTR) Stock Gains After Presidential Praise and ARK Invest Purchase

Key Highlights

• Shares of Palantir advanced 2.3% in pre-market trading to $131.05 on Monday, April 13.
• Former President Trump highlighted the firm on Truth Social, lauding its defense technology as a critical “war fighting” asset.
• ARK Invest, led by Cathie Wood, acquired 85,485 shares of PLTR distributed among five exchange-traded funds, totaling approximately $10.95–$11.15 million.
• The ARKK fund accounted for the largest portion with 46,455 shares, while ARKQ, ARKW, ARKF, and ARKX also increased their holdings.
• Year-to-date, PLTR remains down 28% in 2026 and currently trades at 99 times projected 2026 earnings.

Shares of Palantir received a boost Monday morning thanks to a combination of high-profile support: an endorsement from the presidential level and substantial investment activity from Cathie Wood’s firm.

The stock climbed 2.3% in pre-market hours, reaching $131.05 before regular trading commenced. This upward movement occurred despite broader market weakness — S&P 500 futures declined 0.6% as concerns mounted over Trump’s directive ordering the U.S. Navy to establish a blockade in the Strait of Hormuz.

Palantir Technologies Inc., PLTR

Last Friday, Trump took to Truth Social to declare: “Palantir Technologies (PLTR) has proven to have great war fighting capabilities and equipment. Just ask our enemies!!!” This statement helped PLTR recover some ground during a trading session already affected by market anxiety surrounding Anthropic’s newest artificial intelligence model release.

This isn’t the first instance where presidential commentary has influenced the stock’s trajectory, and market watchers expect such catalysts to continue.

Cathie Wood’s ARK Makes Significant PLTR Investment

According to ARK Invest’s publicly disclosed trading activity for April 11, the investment firm acquired 85,485 Palantir shares distributed across five of its actively managed exchange-traded funds. The aggregate investment value ranged from approximately $10.95 million to $11.15 million, based on varying price points.

The flagship ARKK fund represented the most substantial allocation, purchasing 46,455 shares. ARKQ contributed 15,127 shares to the total, ARKW acquired 11,865, ARKF purchased 5,973, and ARKX rounded out the buying with 6,065 shares.

Wood has maintained a consistently bullish stance on Palantir for an extended period. Given the stock’s significant decline from peak levels, this acquisition appears to represent ARK’s strategy of accumulating shares during price weakness in a high-conviction holding.

Simultaneously, ARK divested 44,446 shares of AMD valued at approximately $10.52 million across the same fund family. The firm also liquidated 75,389 shares of Strata Critical Medical (SRTA) for roughly $305,000, extending its ongoing reduction of that position.

Valuation Concerns Persist Despite Recent Gains

Notwithstanding the favorable news flow, Palantir continues to face significant headwinds throughout 2026. The stock has tumbled 28% since the beginning of the year, representing a substantial retreat from the elevated levels achieved in late 2025.

The central debate among investors centers on valuation metrics. Trading at 99 times anticipated 2026 earnings, the market is embedding substantial growth expectations into the current price. Critics question whether Palantir can achieve the necessary growth velocity to justify this premium — particularly as artificial intelligence developments transform the competitive dynamics within its software sector.

This fundamental tension between robust government and defense sector demand and elevated valuation multiples has characterized the stock’s narrative throughout the current year.

Monday’s pre-market activity positioned PLTR near $131.05. ARK’s share acquisition executed at Friday’s closing price, when the stock changed hands around $128.